Is Medico Intercontinental Ltd (539938) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Medico Intercontinental Ltd is a average quality company .

Is Medico Intercontinental Ltd (539938) undervalued or overvalued?

The key valuation ratios of Medico Intercontinental Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Medico Intercontinental Ltd (539938) share price return in the past 10 years?

Data is not available for this company

Is Medico Intercontinental Ltd (539938) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Medico Intercontinental Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Medico Intercontinental Ltd (539938)?

Company share prices are keep on changing according to the market conditions. The current trading price of Medico Intercontinental Ltd (539938) on 10-Apr-2026 16:59:59 at 16:59 is 29.56.

What is the P/E ratio of Medico Intercontinental?

The latest standalone P/E ratio of Medico Intercontinental as of 10-Apr-2026 is 12.90.

What is the P/B ratio of Medico Intercontinental Ltd (539938)?

The latest standalone P/B ratio of Medico Intercontinental Ltd (539938) as of 10-Apr-2026 is 0.73.

What is the 52-week high and low of Medico Intercontinental Ltd (539938)?

The 52-week high of Medico Intercontinental Ltd (539938) is Rs. 43.00 and the 52-week low is Rs. 25.39.

Medico Intercontinental Ltd (539938) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Medico Intercontinental Ltd (539938)
Brand: Medico Intercontinental

Medico Intercontinental Ltd (539938) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹30 Cr.

P/E Ratio

12.90

Price to Book (P/B)

0.73

Price to Sales (P/S)

0.55

EV/EBITDA

7.85

Return on Capital Employed (ROCE)

9.55%

Current Price

₹29.6

Return on Equity (ROE)

6.86%

Return on Assets (ROA)

5.23%

Operating Profit Margin

6.4%

Net Profit Margin

3.82%

Gross Profit Margin

6.2%

Book Value per Share

₹40.4

Sales Growth (YoY)

52.43%

Sales Growth (3 Years)

19.59%

Operating Profit Growth (1 Year)

64.75%

Operating Profit Growth (3 Years)

23.55%

Net Profit Growth (1 Year)

35.26%

52-Week Low / High

₹25 / 43

Net Profit Growth (3 Years)

25.05%

Dividend Yield

0.00%

Promoter Holding

57.15%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1

Medico Intercontinental Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.

Q.1 Gross Profit margin of Medico Intercontinental Ltd?

Medico Intercontinental Ltd Gross profit margin which is the profit after deduction of direct costs, is 6.2% for FY-2025 , which is above its 5 year median of 0% , indicating increasing margins.

Q.1 Promoter shareholding and pledge status of Medico Intercontinental Ltd?

Promoters hold 57.15% of the Medico Intercontinental Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Medico Intercontinental Ltd vs industry peers?

Medico Intercontinental Ltd revenue CAGR is 7.42% , compared to the industry median CAGR of 17.75% , indicating slower growth and losing its market share.

Q.1 Stock return of Medico Intercontinental Ltd over the last decade?

Over the last 9 years, the stock has delivered a CAGR of 0% based on the current price.

Q.1 Is Medico Intercontinental Ltd a good quality company?

Medico Intercontinental Ltd is a quality company, based on a 10 year financial track record .

DeciZen - make an informed investing decision on Medico Intercont.

Based on:

Data

M-Cap below 100cr DeciZen not available

Medico Intercontinental stock performance

Key Ratios

Is Medico Intercontinental Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-2.7%	0.4%	1.4%	29%	25.2%	19.6%	18.8%	10.9%	7.7%	9.6%	-
Value Creation Index ⓘ	-1.2	-1.0	-0.9	1.1	0.8	0.4	0.3	-0.2	-0.5	-0.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0.1	2	0	10	46.9	41	39.3	48.9	44	67.1	54
Sales YoY Gr.	-	1,930%	-100%	NA	371.7%	-12.6%	-4.3%	24.5%	-9.9%	52.4%	-
Adj EPS ⓘ	-0.2	0.2	0.1	2.3	3.4	3.7	4	1.7	1.9	2.6	2.3
YoY Gr.	-	NA	-40%	2500%	47%	7%	9.8%	-57.9%	11.8%	35.3%	-
BVPS (₹) ⓘ	0	0	10.1	12.4	15.8	19.5	23.6	34.3	36.1	38.7	40.4
Adj Net Profit ⓘ	-0.1	0.1	0	0.8	1.1	1.2	1.3	1.7	1.9	2.6	2
Cash Flow from Ops. ⓘ	0.1	-0	0	1	-6.6	5.4	1.1	-12	5.7	-6.8	-
Debt/CF from Ops. ⓘ	1.9	-0.6	1.2	0.1	-1.3	0.9	5.7	-0.2	0.2	-2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	106.1%	7.4%	19.6%	52.4%
Adj EPS ⓘ	NA	-5.7%	-14%	35.3%
BVPSⓘ	NA	19.5%	18%	7.1%
Share Price	-	3.9%	-28.7%	-25.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-1.9	1.5	0.9	20.9	24.4	20.8	18.8	8.1	5.4	6.9	5.8
Op. Profit Mgn % ⓘ	-227.4	3.3	0	7.3	4.8	5.7	5.8	5.1	5.9	6.4	6.6
Net Profit Mgn % ⓘ	-62	2.4	0	7.6	2.4	2.9	3.3	3.5	4.3	3.8	4.3
Debt to Equity ⓘ	0.1	0	0	0	1.7	0.8	0.8	0.1	0	0.3	-
Working Cap Days ⓘ	12,206	658	0	214	90	120	110	174	278	213	95
Cash Conv. Cycle ⓘ	69	103	0	51	47	72	60	104	158	100	79

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	2.3	-1.4
TTM Sales (₹ Cr.)	53.9	83
BVPS (₹) ⓘ	40.4	46.1
Reserves (₹ Cr.) ⓘ	30	36
P/BV ⓘ	0.73	0.64
PE ⓘ	12.90	0.00

From the Market
52 Week Low / High (₹)	25.39 / 43.00
All Time Low / High (₹)	8.00 / 132.10
Market Cap (₹ Cr.)	29.6
Equity (₹ Cr.)	10
Face Value (₹)	10
Industry PE ⓘ	24.2

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Medico Intercont. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0.10	2.03	0	9.95	46.93	41.02	39.25	48.88	44.04	67.13
Operating Expenses ⓘ +	0.32	1.96	0.34	9.23	44.69	38.68	36.97	46.39	41.43	62.83
Manufacturing Costs	0.23	0.03	0.03	0.04	0.06	0.03	0.02	0.02	0.02	0.02
Material Costs	0.07	1.86	0.21	8.90	41.94	35.78	34.06	42.12	36.58	56.08
Employee Cost	0.01	0.05	0.06	0.03	0.87	0.74	0.79	0.96	0.99	1.14
Other Costs ⓘ	0.01	0.03	0.04	0.26	1.82	2.14	2.10	3.29	3.84	5.59
Operating Profit ⓘ	-0.22	0.07	-0.34	0.72	2.25	2.34	2.28	2.49	2.61	4.30
Operating Profit Margin (%)	-227.0%	3.3%	-	7.3%	4.8%	5.7%	5.8%	5.1%	5.9%	6.4%
Other Income ⓘ +	0.13	0	0.39	0.36	0.02	0.16	0.18	0.34	0.42	0.51
Exceptional Items ⓘ	0	-0.05	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0.05	0.71	0.78	0.52	0.37	0.22	0.67
Depreciation ⓘ	0	0	0	0	0.02	0.06	0.10	0.09	0.18	0.56
Profit Before Tax ⓘ	-0.09	0.01	0.05	1.03	1.54	1.66	1.83	2.38	2.62	3.58
Tax ⓘ	-0.03	0	0.02	0.27	0.42	0.47	0.52	0.67	0.73	1.01
Profit After Tax	-0.06	0.01	0.03	0.76	1.12	1.20	1.31	1.70	1.90	2.57
PAT Margin (%)	-62.0%	0.6%	-	7.6%	2.4%	2.9%	3.3%	3.5%	4.3%	3.8%
Adjusted EPS (₹)	-0.2	0.0	0.1	2.3	3.4	3.7	4.0	1.7	1.9	2.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	6%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	3.23	3.24	3.27	4.03	5.15	6.34	7.65	34.30	36.10	38.66
Share Capital ⓘ	3.25	3.25	3.25	3.25	3.25	3.25	3.25	10	10	10
Reserves ⓘ	-0.02	-0.01	0.02	0.78	1.90	3.09	4.40	24.30	26.10	28.66
Debt +	0.23	0.02	0.02	0.09	8.52	4.78	5.86	1.94	0.80	12.77
Long Term Debt	0	0.02	0.02	0.09	8.52	4.78	5.86	1.94	0.80	12.77
Short Term Debt	0.23	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.05	0.71	0.61	4.89	5.20	5.02	3.71	7.48	1.93	5.59
Others Liabilities ⓘ	-0.01	0.18	-0.01	0.09	0.29	0.26	0.46	0.61	0.54	1.74
Total Liabilities ⓘ	3.50	4.16	3.89	9.11	19.16	16.40	17.68	44.33	39.37	58.76
Fixed Assets
Net Fixed Assets ⓘ +	0	0.01	0.01	0	0.12	0.24	0.20	0.48	0.33	1.68
Gross Block	0	0.01	0.01	0.01	0.15	0.34	0.40	0.76	0.80	2.67
Accumulated Depreciation	0	0	0	0.01	0.03	0.09	0.20	0.29	0.46	0.99
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0.03	3.57	4.35	4.20	4.20	4.20	7.19
Inventories	0	0	0	0.63	2.56	3.56	2.47	3.69	4.57	2.94
Trade Receivables	0.05	1.89	1.33	6.47	12.67	8.03	8.48	24.92	14.93	22.77
Cash Equivalents	0.20	0.14	0.16	1.15	0.14	0.12	1.29	4.95	2.41	1.42
Others Assets ⓘ	3.25	2.11	2.39	0.83	0.11	0.10	1.05	6.09	12.93	22.76
Total Assets ⓘ	3.50	4.16	3.89	9.11	19.16	16.40	17.68	44.33	39.37	58.76

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.12	-0.04	0.02	0.95	-6.55	5.44	1.10	-11.95	5.73	-6.78
PBT ⓘ	-0.09	0.01	0.05	1.03	1.54	1.66	1.83	2.38	2.62	3.58
Adjustment ⓘ	0	0	0	0	0.02	0.82	0.56	0.21	0.12	0.95
Changes in Working Capital ⓘ	0.18	-0.05	-0.03	0.11	-7.85	3.43	-0.67	-13.88	3.6	-10.3
Tax Paid ⓘ	0.03	0	0	-0.20	-0.26	-0.48	-0.62	-0.65	-0.61	-1
Cash Flow From Investing Activity ⓘ +	0	-0.01	0	-0.03	-3.68	-0.94	-0.80	-5.02	-6.65	-4.78
Capex	0	-0.01	0	0	-0.14	-0.18	-0.06	-0.37	-0.03	-4.62
Net Investments	0	0	0	-0.03	-3.54	-0.78	0.15	0	0	-2.99
Others ⓘ	0	0	0	0	-0	0.02	-0.89	-4.66	-6.61	2.83
Cash Flow From Financing Activity ⓘ +	0	0	0	0.07	9.22	-4.51	0.87	20.63	-1.63	10.57
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	24.94	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	-3.74	1.07	-3.92	-1.14	11.97
Interest Paid ⓘ	0	0	0	0	0	-0.78	-0.52	-0.37	-0.22	-0.67
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	-0.10	0
Others ⓘ	0	0	0	0.07	9.22	0	0.32	-0.02	-0.17	-0.73
Net Cash Flow ⓘ	0.12	-0.05	0.02	0.99	-1.01	-0.02	1.17	3.66	-2.54	-0.99

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-1.87	0.35	0.91	20.81	24.39	20.81	18.75	8.13	5.39	6.86
ROCE (%)	-2.68	0.38	1.41	29.03	25.2	19.63	18.78	10.89	7.73	9.55
Asset Turnover Ratio	0.03	0.53	0	1.53	3.32	2.31	2.3	1.58	1.05	1.37
PAT to CFO Conversion(x)	N/A	-4	0.67	1.25	-5.85	4.53	0.84	-7.03	3.02	-2.64
Working Capital Days
Receivable Days	198	175	0	143	74	92	77	125	165	102
Inventory Days	0	0	0	23	12	27	28	23	34	20
Payable Days	141	75	1,134	113	44	52	47	49	47	24

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Medico Intercontinental Ltd FAQs

The current trading price of Medico Intercont. on 10-Apr-2026 16:59 is ₹29.56.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Apr-2026 the market cap of Medico Intercont. stood at ₹29.56 Cr

The latest P/E ratio of Medico Intercont. as of 09-Apr-2026 is 12.90.

The latest P/B ratio of Medico Intercont. as of 09-Apr-2026 is 0.73.

The 52-week high of Medico Intercont. is ₹43.00 and the 52-week low is ₹25.39.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medico Intercont. is ₹53.88 ( Cr.) .

About Medico Intercontinental Ltd

Medico Intercontinental (formerly known as Intercontinental Leasing and Finance Company) was incorporated on August 14, 1984 having its Registered Office at Ahmedabad, Gujarat.

The company is providing a platform to all research based biopharmaceutical companies reaching their Novel and innovative therapies to every part of the globe.

From helping people obtain their medications to using cutting-edge scientific technology to discover new treatments, Medico’s entrepreneurial spirit, teamwork-oriented culture and commitment to rare diseases create a unique platform for transforming patient outcomes. At every level, it is growing and evolving.

Business area of the company

The company is into the business of trading of Pharmaceutical Products.

Products

Gastro
Uro
Nutrition
Cosmetology
Health Devices
Hospital

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Medico Intercontinental Ltd (539938) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Medico Intercont. Share Price